Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > PAR2


Brief Information

Name:Protease-activated receptor-2
Target Synonym:Receptor, PAR-2,F2RL1,Thrombin receptor-like 1,G-protein coupled receptor 11,F2R Like Trypsin Receptor 1,PAR2,GPR11,Protease-Activated Receptor 2,Coagulation Factor II (Thrombin) Receptor-Like 1,Proteinase-Activated Receptor-2,Proteinase-activated receptor 2,Coagulation factor II receptor-like 1
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:3
Lastest Research Phase:Phase 1 Clinical

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
PA2-H52P7 Human Human PAR2 Full Length Protein (VLP)
ACRO Quality

Part of Bioactivity data


Immobilized Human PAR2 Full Length Protein (VLP) (Cat. No. PA2-H52P7) at 5 μg/mL (100 μL/well) can bind Anti-PAR2 Antibody, Human IgG1 with a linear range of 1-39 ng/mL (QC tested).

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
TEV-56192 TEV-56192 Phase 1 Clinical Teva Pharmaceutical Industries Ltd Nervous System Diseases Details
OA-235i OA-235i Phase 1 Clinical Oasis Pharmaceuticals LLC Metabolic Dysfunction-Associated Steatotic Liver Disease Details
MEDI-0618 MEDI-0618 Phase 1 Clinical Astrazeneca Plc Chronic Pain Details

This web search service is supported by Google Inc.

Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
+1 888-377-6111
1 Innovation Way, Newark, DE 19711, USA

Leave a message